xibility to deploy capital to drive shareholder return. Next catalyst will be 2Q eamings/2H16 Outlook on 8/8. AGN Is on our firm's US-1 list of best Investment Ideas. Teva Pharma (TEVA) - BAML reiterating BUY on TEVA after the FTCs approval of AGN generics deal. We continue to like TEVA's positioning In generic p

m: Institutional Investor Daily Sent: Tuesday, June 12, 2012 2:3 To: [email protected] Subject: Samena Capital Taps Tycoon Shareholders for Investment Ideas chttp://projectsline.com/iimag/images=x.gif> <http://ems.euromoney.com/ems/r.asp?clndex=666507&=Index=1263530385&hurl=http%3A//www.institution ali